Skip to content

Phastar Sponsor ACDM19

Date: September 3, 2018

The Association for Clinical Data Management are delighted to announce that PHASTAR are the ACDM19 Networking & Premier Sponsor. ACDM19, the ACDM Annual Conference, will take place on the 11th and 12th March 2019 in Amsterdam.

PHASTAR is a specialist CRO offering statistical consulting and clinical trial reporting services to the pharmaceutical, biotech and medical device industries. Our number one priority is to ensure the work we produce is of the highest quality: every project PHASTAR undertakes is supervised on methodology and utilises unique internal processes designed to ensure the best quality.

PHASTAR is known as a CRO of quality: over the last decade, we have been involved in the design and reporting of hundreds of studies, and each has been delivered on-time and with no issues. Talk to us about using MEDRIO for your study – MEDRIO is fully functional, easy to use, and sensibly priced and PHASTAR can provide data collection as a MEDRIO partner.

E: tellmemore@phastar.com

W: http://www.phastar.com/

 


 

Explore More News

AI Symposium Session Summary: Is AI in clinical trials delivering measurable ROI?

At the 4th Annual ACDM Symposium on Artificial Intelligence (AI) in Clinical Trials, the . . .

Read More

Newsletter Committee: Meet Neha

The ACDM is delighted to welcome Neha Shah of ITM to the Newsletter Committee. Neha shares . . .

Read More

Newsletter Committee: Meet Sylvain

The ACDM is delighted to welcome Sylvain Berthelot of CRScube to the Newsletter . . .

Read More

Welcome VHypotenuse as a corporate member

The ACDM: Association for Clinical Data Management is delighted to welcome VHypotenuse as . . .

Read More

Newsletter Committee: Meet Marta

The ACDM is delighted to welcome Marta Kowalska of CluePoints to the Newsletter . . .

Read More

AI model trained on de-identified data from 57 million people

Researchers at UCL have trained an AI model using de-identified data from 57 million . . .

Read More

ACDM Regulatory Considerations DMEG Update: ICH E6 (R3) GCP Final Publication Released

The final publication of ICH E6 (R3) Good Clinical Practice (GCP) General Principles and . . .

Read More

ICH E6(R3) Guideline reaches Step 4 of the ICH Process

ICH E6(R3) reaches Step 4 of the ICH Process on 6th January 2025. The guideline . . .

Read More

U.S. Food & Drug Administration: Draft Guidance for Industry and Other Interested Parties

The U.S. Food and Drug Administration has issued its first guidance on the use of . . .

Read More

ACDM DMEG News: Regulatory Updates and Forthcoming Challenges for 2025

As 2024 draws to a close, the Regulatory Considerations Data Management Expert Group . . .

Read More

Audit Trail Review DMEG Update – New Guide

The Audit Trail Review (ATR) DMEG has been hard at work putting the finishing touches on a . . .

Read More

Risk Based Quality Management DMEG Update – Recent Discussions

This year our focus has switched away from generalised RBQM to applying risk-based . . .

Read More